Venlafaxine and duloxetine alleviate symptoms better than sham drug: The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) drug class. Up till now, 2 of these drugs have been approved as antidepressants in Germany: venlafaxine and duloxetine.
Popularity: 1% [?]
Related posts:
- Auspex Pharmaceuticals Announces Positive Results From Clinical Study Of SD-254, A Next-Generation Potential Treatment For Depression
- Auspex Pharmaceuticals Announces Positive Results From Clinical Study Of SD-254, A Next-Generation Potential Treatment For Depression
- FDA Approves Pristiq For The Treatment Of Adult Patients With Major Depressive Disorder
- Clinical Data, Inc. Announces Publication Of Results From First Phase III Study Of Vilazodone In Treatment Of Major Depressive Disorder
- Wyeth’s Pristiq, A New Treatment For Major Depressive Disorder
Comments
No Responses to “Antidepressants: Benefit Of SNRI Is Proven”